Validation of low-dose aspirin prescription data in The Health Improvement Network: How much misclassification due to over-the-counter use?

Pharmacoepidemiology and Drug Safety

Volumn 25, Issue 4, 2016, Pages 392-398

  Cea Soriano, Lucía ^a   Soriano Gabarró, Montse ^b   García Rodríguez, Luis A ^b  

^a Spanish Centre for Pharmacoepidemiologic Research ^*  (Spain)

^b BAYER PHARMA AG   (Germany)

Author keywords

Low dose aspirin; Nonprescription drugs; Over the counter drugs; Pharmacoepidemiology

Indexed keywords

ACETYLSALICYLIC ACID; DICLOFENAC; ETORICOXIB; IBUPROFEN; LANSOPRAZOLE; NAPROXEN; NON PRESCRIPTION DRUG; OMEPRAZOLE; PIROXICAM; RANITIDINE; ANTITHROMBOCYTIC AGENT; PRESCRIPTION DRUG;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG CLASSIFICATION; DRUG USE; FEMALE; GENERAL PRACTITIONER; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON PRESCRIPTION DRUG USE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRESCRIPTION; PRIMARY PREVENTION; PRIORITY JOURNAL; QUESTIONNAIRE; SECONDARY PREVENTION; VERY ELDERLY; CARDIOVASCULAR DISEASES; FACTUAL DATABASE; PRIMARY HEALTH CARE; STATISTICS AND NUMERICAL DATA; UNITED KINGDOM; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; ASPIRIN; CARDIOVASCULAR DISEASES; DATABASES, FACTUAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NONPRESCRIPTION DRUGS; PLATELET AGGREGATION INHIBITORS; PRESCRIPTION DRUGS; PRIMARY HEALTH CARE; PRIMARY PREVENTION; SECONDARY PREVENTION; SURVEYS AND QUESTIONNAIRES; UNITED KINGDOM;

EID: 84949947621     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3926     Document Type: Article

References (25)

1. García Rodríguez LA, Cea-Soriano L, Martin-Merino E, et al. Discontinuation of low dose aspirin and risk of myocardial infarction: case-control study in UK primary care. BMJ 2011; 343:d4094.
2. García Rodríguez LA, Cea Soriano L, Hill C, et al. Increased risk of stroke after discontinuation of acetylsalicylic acid: a UK primary care study. Neurology 2011; 76(8): 740-746.
3. García Rodríguez LA, Soriano-Gabarró M, Cea Soriano L. Low-dose acetylsalicylic acid and risk of colorectal cancer: evidence from a primary care study in the UK. Gastroenterology 2015; 148(4 Supplement 1:S-37).
4. García Rodríguez LA, Lin KJ, Hernandez-Diaz S, et al. Risk of upper gastrointestinal bleeding with low-dose acetylsalicylic acid alone and in combination with clopidogrel and other medications. Circulation 2011; 123(10): 1108-1115.
5. Lin KJ, De Caterina R, García Rodríguez LA. Low-dose aspirin and upper gastrointestinal bleeding in primary versus secondary cardiovascular prevention: a population-based, nested case-control study. Circ Cardiovasc Qual Outcomes 2014; 7(1): 70-77.
6. Walker AJ, Grainge MJ, Card TR. Aspirin and other non-steroidal anti-inflammatory drug use and colorectal cancer survival: a cohort study. Br J Cancer 2012; 107(9): 1602-1607.
7. Gallagher AM, Rietbrock S, Plumb J, et al. Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis? J Thromb Haemost 2008; 6(9): 1500-1506.
8. Lin CC, Lai MS, Shau WY. Can aspirin reduce the risk of colorectal cancer in people with diabetes? A population-based cohort study. Diabet Med 2015; 32(3): 324-331.
9. Macfarlane TV, Lefevre K, Watson MC. Aspirin and non-steroidal anti-inflammatory drug use and the risk of upper aerodigestive tract cancer. Br J Cancer 2014; 111(9): 1852-1859.
10. Cea Soriano L, Bueno H, Lanas A, et al. Cardiovascular and upper gastrointestinal bleeding consequences of low-dose acetylsalicylic acid discontinuation. Thromb Haemost 2013; 110(6): 1298-1304.
11. Saez ME, Gonzalez-Perez A, Johansson S, et al. Patterns in the use of low-dose acetylsalicylic acid and other therapies following upper gastrointestinal bleeding. Am J Cardiovasc Drugs 2014; 14(6): 443-450.
12. Martin-Merino E, Johansson S, Nagy P, et al. Represcription of low-dose acetylsalicylic acid after discontinuation in patients receiving treatment for secondary cardiovascular disease prevention in the UK. Am J Cardiovasc Drugs 2014; 14(4): 319-326.
13. Bourke A, Dattani H, Robinson M. Feasibility study and methodology to create a quality-evaluated database of primary care data. Inform Prim Care 2004; 12(3): 171-177.
14. CSD Medical Research UK. Available at: http://csdmruk.cegedim.com/ [13 January 2015].
15. Stuart-Buttle CD, Read JD, Sanderson HF, et al.. A language of health in action: Read Codes, classifications and groupings. Proc AMIA Annu Fall Symp 1996: 75-79.
16. In Practice Systems Ltd. Gemscript  The new DM+D drug dictionary for Vision. Available at: http://www.inps4.co.uk/my-vision/news/gemscript-%C3%82%C2%96-new-dmd-drug-dictionary-vision [13 January 2015].
17. Blak BT, Thompson M, Dattani H, et al. Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates. Inform Prim Care 2011; 19(4): 251-255.
18. Bedson J, Whitehurst T, Lewis M, et al. Factors affecting over-the-counter use of aspirin in the secondary prophylaxis of cardiovascular disease. Br J Gen Pract 2001; 51(473): 1001-1003.
19. Yang YX, Hennessy S, Propert K, et al. Chronic statin therapy and the risk of colorectal cancer. Pharmacoepidemiol Drug Saf 2008; 17(9): 869-876.
20. Hopper S, Pierce M. Aspirin after myocardial infarction: the importance of over-the-counter use. Fam Pract 1998; 15(Suppl 1): S10-S13.
21. Campbell NC, Thain J, Deans HG, et al. Secondary prevention in coronary heart disease: baseline survey of provision in general practice. BMJ 1998; 316(7142): 1430-1434.
22. Goh LY, Vitry AI, Semple SJ, et al. Self-medication with over-the-counter drugs and complementary medications in South Australia's elderly population. BMC Complement Altern Med 2009; 9: 42.
23. Martín-Merino EJS, Bueno H, García Rodríguez LA. Discontinuation of low-dose acetylsalicylic acid therapy in UK primary care: incidence and predictors in patients with cardiovascular disease. Pragmat Obs Res 2012; 3: 1-9.
24. Cea Soriano L, Rodriguez LA. Risk of upper gastrointestinal bleeding in a cohort of new users of low-dose ASA for secondary prevention of cardiovascular outcomes. Front Pharmacol 2010; 1: 126.
25. Elwood P, Morgan G, White J, et al. Aspirin taking in a South Wales county. Br J Cardiol 2011; 18: 238-240.